
Please try another search
Symbol | Exchange | Currency | ||
---|---|---|---|---|
RHHBY | OTC Markets | USD | Delayed | |
RHHVF | OTC Markets | USD | Delayed | |
ROGz | BATS Europe | CHF | Delayed | |
ROz | BATS Europe | CHF | Delayed | |
0QQ6 | London | CHF | Real-time | |
0QOK | London | CHF | Real-time | |
ROGN | Mexico | MXN | Delayed | |
ROG | Switzerland | CHF | Delayed | |
RO | Switzerland | CHF | Delayed | |
RO | Frankfurt | EUR | Delayed | |
RHO6y | Frankfurt | EUR | Delayed |
Roche Holding AG (Roche) is a research-based healthcare company. The Company's operating businesses are organized into two divisions: Pharmaceuticals and Diagnostics. The Pharmaceuticals Division consists of two business segments: Roche Pharmaceuticals and Chugai. The Diagnostics Division consists of four business areas: Diabetes Care, Molecular Diagnostics, Professional Diagnostics and Tissue Diagnostics. The Company develops medicines for various disease areas, including oncology, immunology, infectious diseases, ophthalmology and neuroscience. Its pharmaceutical products include Anaprox, Avastin, Bactrim, Bondronat, CellCept, Cotellic, Dilatrend, Dormicum, Invirase, Kadcyla, Kytril (Kevatril), Lariam, MabThera, Madopar, Neupogen, Pegasys, Perjeta, Pulmozyme, Rocaltrol, Rocephin and Roferon-A. The Company offers products for researchers, including cell analysis, gene expression, genome sequencing and nucleic acid purification.
Name | Age | Since | Title |
---|---|---|---|
Bernard J. Poussot | 71 | 2015 | Non-Executive Independent Director |
Andre S. Hoffmann | 65 | 1996 | Independent Vice Chairman |
Claudia Suessmuth Dyckerhoff | 56 | 2016 | Non-Executive Independent Director |
Richard P. Lifton | 70 | 2015 | Non-Executive Independent Director |
Jorg Duschmale | 39 | 2020 | Non-Executive Independent Director |
Patrick Frost | 55 | 2020 | Independent Non Executive Director |
Anita Hauser | 54 | 2017 | Non-Executive Independent Director |
Jemilah Mahmood | - | 2022 | Independent Non-Executive Director |
Ulf Mark Schneider | 58 | 2023 | Director |
Akiko Iwasaki | - | 2023 | Director |
Severin Schwan | 56 | 2006 | CEO & Executive Chairman |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review